STOCK TITAN

Hercules Capital 6.25% Notes due 2033 (HCXY) 424B Filings

HCXY NYSE

Here are the 424B prospectus supplements from Hercules Capital, Inc. 6.25% Notes due 2033 (HCXY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow HCXY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HCXY filings page.

Rhea-AI Summary

Hercules Capital, Inc. is offering $400 million aggregate principal amount of unsecured 6.700% notes due October 8, 2029. The notes are priced at 99.379% of principal and have a 6.933% yield to maturity. Interest accrues from October 8, 2026 and is payable semiannually on April 8 and October 8, beginning April 8, 2027.

The company estimates net proceeds of approximately $392.6 million after the underwriting discount and estimated offering expenses. It intends to use the proceeds to repay outstanding unsecured and/or secured indebtedness, fund investments in accordance with its investment objectives, and for other general corporate purposes. As of October 1, 2026, total consolidated indebtedness at par was approximately $2.6 billion.

The notes will not be guaranteed by the company’s subsidiaries and rank pari passu with liabilities that are not subordinated. They are effectively subordinated to secured debt to the value of the collateral and structurally subordinated to subsidiary liabilities. The notes will not be listed on an exchange, and underwriters are not obligated to make a market. Following a Change of Control Repurchase Event, holders may require repurchase at 100% of principal plus accrued and unpaid interest.

Rhea-AI Summary

Hercules Capital, Inc. outlines a preliminary primary offering of unsecured notes, with net proceeds intended to repay outstanding unsecured and/or secured indebtedness, fund investments under its investment objectives, and support other general corporate purposes.

The notes would rank equally with unsubordinated liabilities, behind secured debt to the extent of collateral value, and behind subsidiary liabilities. Holders could require repurchase at 100% of principal plus accrued and unpaid interest after a Change of Control Repurchase Event. Hercules may redeem the notes at its option. It does not intend to list them on an exchange, and a liquid market is not assured.

Separately, Hercules issued $325.0 million of 6.300% unsecured notes due July 24, 2031, and repaid $325.0 million of 2.625% notes at maturity on September 16, 2026. Consolidated indebtedness was approximately $2.6 billion as of October 1, 2026. Its asset coverage ratio was 212.2% as of June 30, 2026, excluding SBA debentures under SEC exemptive relief.

Rhea-AI Summary

Hercules Capital, Inc. is offering $300,000,000 aggregate principal amount of 5.350% unsecured notes due February 10, 2029. The notes pay cash interest semi-annually on February 10 and August 10, starting August 10, 2026, and were priced at 99.272% of par, implying proceeds slightly below face value.

The notes rank equally with Hercules Capital’s other unsecured unsubordinated debt, but are effectively subordinated to secured borrowings and structurally subordinated to debt at subsidiaries. Hercules may redeem the notes early, and holders can require repurchase at 100% of principal plus accrued interest following a Change of Control Repurchase Event.

Net proceeds of about $294 million are intended to fund new investments consistent with the company’s business development company strategy, repay amounts outstanding under the SMBC and MUFG bank facilities, and support other general corporate purposes, preserving balance-sheet flexibility while expanding its specialty finance lending capacity.

Rhea-AI Summary

Hercules Capital, Inc., an internally managed business development company focused on senior secured lending to venture-backed technology and life sciences firms, is offering a new series of unsecured notes. The notes pay semi-annual cash interest and mature in 20__, with optional redemption by the company.

The notes rank equally with Hercules Capital’s other unsecured unsubordinated debt and are effectively subordinated to secured borrowings and structurally subordinated to liabilities at its subsidiaries. Holders can require repurchase at 100% of principal plus accrued interest after a Change of Control Repurchase Event.

Net proceeds are expected to fund new investments, repay borrowings under the SMBC and MUFG Bank credit facilities, and support general corporate purposes. The filing also details significant existing debt, asset coverage requirements as a BDC, and extensive risk factors around leverage, limited covenants, interest-rate sensitivity, liquidity of the notes, and unaudited preliminary financial estimates.